Androgen receptor gene mutations in hormone-refractory prostate cancer

Journal of Pathology

Volumn 189, Issue 4, 1999, Pages 559-563

  Wallén, Mika J ^a   Linja, Marika ^a   Kaartinen, Kaius ^a   Schleutker, Johanna ^a   Visakorpi, Tapio ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Androgen; Mutation; Prostate cancer; Receptors; Trinucleotide repeats

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0032695582     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199912)189:4<559::AID-PATH471>3.3.CO;2-P     Document Type: Article

References (31)

1. Waxman J. Introduction: basic science aspects of prostate cancer. Semin Cancer Biol 1997; 8: 1.
2. Gittes RF. Carcinoma of the prostate. N Engl J Med 1991; 324: 236-245.
3. Steams ME, McGarvey T. Biology of disease. Prostate cancer: therapeutic, diagnostic, and basic studies. Lab Invest 1992; 67: 540-552.
4. Kallioniemi O-P, Visakorpi T. Genetic basis and clonal evolution of human prostate cancer. Adv Cancer Res 1996; 68: 225-255.
5. Visakorpi T, Hyytinen E, Koivisto P, et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 1995; 9: 401-406.
6. Koivisto P, Kononen J, Palmberg C, et al. Androgen receptor gene amplification: a possible molecular mechanism for failure of androgen deprivation therapy in prostate cancer. Cancer Res 1997; 57: 314-319.
7. Koivisto P, Kolmer M, Visakorpi T, Kallioniemi O-P. Androgen receptor gene and hormonal therapy failure of prostate cancer. Am J Pathol 1998; 152: 1-9.
8. UICC. TNM. Classification of Malignant Tumours. Springer-Verlag: Berlin, 1987.
9. Mostofi FK. Histological Typing of Prostate Tumours. World Health Organization: Geneva, 1980.
10. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994; 145: 1301-1308.
11. Tilley WD, Buchanan G, Mickey TE, Bentel JM. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res 1996; 2: 277-285.
12. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995; 55: 1937-1940.
13. Giovannucci E, Stampfer MJ, Krithivas K, et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997; 94: 3320-3323.
14. Sadi MV, Walsh PC, Barrack ER. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer 1991; 67: 3057-3064.
15. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, et al. Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int J Cancer 1991; 48: 189-193.
16. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A. Androgen receptor status of lymph node metastases from prostate cancer. Prostate 1996; 28: 129-135.
17. Gottlieb B, Lehvaslaiho H, Beitel LK, Lumbroso R, Pinsky L, Trifiro M. The androgen receptor gene mutations database. Nucleic Acids Res 1998; 26: 234-238.
18. Berrevoets CA, Veldscholte J, Mulder E. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors. J Steroid Biochem Mol Biol 1993; 46: 731-736.
19. Culig Z, Hobisch A, Cronauer MV, et al. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 1993; 7: 1541-1550.
20. 24→18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun 1994; 198: 74-80.
21. Taplin M-E, Bubley GJ, Shuster TD, et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995; 332: 1393-1398.
22. Newmark JR, Hardy DO, Tonb DC, et al. Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A 1992; 89: 6319-6323.
23. Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J. Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 1993; 46: 759-765.
24. Ruizeveld de Winter JA, Janssen PJ. Sleddens HM, et al. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 1994; 144: 735-746.
25. Elo JP, Kvist L, Leinonen K, et al. Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. J Clin Endocrinol Metab 1995; 80: 3494-3500.
26. Evans BAJ, Harper ME, Daniells CE, et al. Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis. Prostate 1996; 28: 162-171.
27. Suzuki H, Akakura K, Komiya A, Aida S, Akimoto S, Shimazaki J. Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome. Prostate 1996; 29: 153-158.
28. Watanabe M, Ushijima T, Shiraishi T, et al. Genetic alterations of androgen receptor gene in Japanese human prostate cancer. Jpn J Clin Oncol 1997; 27: 389-393.
29. Gaddipati JP, McLeod DG, Heidenberg HB, et al. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 1994; 54: 2861-2864.
30. Nupponen NN, Kakkola L, Koivisto P, Visakorpi T. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 1998; 153: 141-148.
31. Hakimi JM, Rondinelli RH, Schoenberg MB, Barrack ER. Androgen receptor gene structure and function in prostate cancer. World J Urol 1996; 14: 329-337.